ACRS
Aclaris Therapeutics Inc.
$3.91
+$0.16(+4.27%)
61
Overall
60
Value
80
Tech
44
Quality
Market Cap
$263.28M
Volume
611.07K
52W Range
$1.05 - $4.89
Target Price
$8.29
EPS Estimates Overview
| Current Quarter | $-0.16 | Next Quarter | $-0.16 |
| Current Year | $-0.62 | Next Year | $-0.63 |
| QoQ Growth | +0.0% | YoY Growth | -1.6% |
| 3Y EPS CAGR | -2.2% | Target Price | $8.29 |
| Consensus | Buy | Upside | +112.0% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ACRS | $3.91 | +4.3% | 611.07K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Aclaris Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW